|
Apr 25
|
Stocks to watch next week: Apple, Microsoft, Shell, HSBC, Lloyds and AstraZeneca
|
|
Apr 24
|
Moderna (MRNA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
|
Apr 24
|
3 Healthcare Stocks Facing Headwinds
|
|
Apr 24
|
Flagship’s latest venture reflects more than 25 years of leaping into the unknown
|
|
Apr 23
|
Why vaccine makers aren't worried about Trump administration cuts
|
|
Apr 20
|
Where Will Moderna Be in 5 Years?
|
|
Apr 17
|
Moderna (MRNA) Stock Drops Despite Market Gains: Important Facts to Note
|
|
Apr 17
|
US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years
|
|
Apr 17
|
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
|
|
Apr 17
|
GSK & PFE's RSV Vaccines Recommended for Use in Adults Aged 50-59
|
|
Apr 16
|
Bloom Energy, Rogers, 3D Systems, Moderna, and EchoStar Stocks Trade Down, What You Need To Know
|
|
Mar 15
|
Down 93%, Is It Finally Time to Buy Moderna?
|
|
Mar 14
|
Markets Rebound, But Short Sellers Are Circling--Is This Rally Built to Last?
|
|
Mar 13
|
Citi says SMid biotechs alternative to large caps as it starts coverage
|
|
Mar 12
|
Moderna (NasdaqGS:MRNA) Up 11% Despite Patent Lawsuit Challenges
|
|
Mar 12
|
3 Reasons MRNA is Risky and 1 Stock to Buy Instead
|
|
Mar 11
|
Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks
|
|
Feb 22
|
Why Moderna Inc. (MRNA) Surged On Friday?
|
|
Feb 21
|
Moderna and Other Vaccine Stocks Climb Amid Concerns About Coronavirus Study in China
|
|
Feb 20
|
Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So.
|